204 related articles for article (PubMed ID: 24132234)
1. LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy.
Goddeeris MM; Wu B; Venzke D; Yoshida-Moriguchi T; Saito F; Matsumura K; Moore SA; Campbell KP
Nature; 2013 Nov; 503(7474):136-40. PubMed ID: 24132234
[TBL] [Abstract][Full Text] [Related]
2. LARGE expression in different types of muscular dystrophies other than dystroglycanopathy.
Balci-Hayta B; Talim B; Kale G; Dincer P
BMC Neurol; 2018 Dec; 18(1):207. PubMed ID: 30553274
[TBL] [Abstract][Full Text] [Related]
3. N-terminal domain on dystroglycan enables LARGE1 to extend matriglycan on α-dystroglycan and prevents muscular dystrophy.
Okuma H; Hord JM; Chandel I; Venzke D; Anderson ME; Walimbe AS; Joseph S; Gastel Z; Hara Y; Saito F; Matsumura K; Campbell KP
Elife; 2023 Feb; 12():. PubMed ID: 36723429
[TBL] [Abstract][Full Text] [Related]
4. Congenital muscular dystrophies involving the O-mannose pathway.
Martin PT
Curr Mol Med; 2007 Jun; 7(4):417-25. PubMed ID: 17584082
[TBL] [Abstract][Full Text] [Related]
5. Glycosyltransferase POMGNT1 deficiency strengthens N-cadherin-mediated cell-cell adhesion.
Noor SI; Hoffmann M; Rinis N; Bartels MF; Winterhalter PR; Hoelscher C; Hennig R; Himmelreich N; Thiel C; Ruppert T; Rapp E; Strahl S
J Biol Chem; 2021; 296():100433. PubMed ID: 33610554
[TBL] [Abstract][Full Text] [Related]
6. Intragenic deletion in the LARGE gene causes Walker-Warburg syndrome.
van Reeuwijk J; Grewal PK; Salih MA; Beltrán-Valero de Bernabé D; McLaughlan JM; Michielse CB; Herrmann R; Hewitt JE; Steinbrecher A; Seidahmed MZ; Shaheed MM; Abomelha A; Brunner HG; van Bokhoven H; Voit T
Hum Genet; 2007 Jul; 121(6):685-90. PubMed ID: 17436019
[TBL] [Abstract][Full Text] [Related]
7. POMK regulates dystroglycan function via LARGE1-mediated elongation of matriglycan.
Walimbe AS; Okuma H; Joseph S; Yang T; Yonekawa T; Hord JM; Venzke D; Anderson ME; Torelli S; Manzur A; Devereaux M; Cuellar M; Prouty S; Ocampo Landa S; Yu L; Xiao J; Dixon JE; Muntoni F; Campbell KP
Elife; 2020 Sep; 9():. PubMed ID: 32975514
[TBL] [Abstract][Full Text] [Related]
8.
Yonekawa T; Rauckhorst AJ; El-Hattab S; Cuellar MA; Venzke D; Anderson ME; Okuma H; Pewa AD; Taylor EB; Campbell KP
Sci Adv; 2022 May; 8(21):eabn0379. PubMed ID: 35613260
[TBL] [Abstract][Full Text] [Related]
9. FKRP-dependent glycosylation of fibronectin regulates muscle pathology in muscular dystrophy.
Wood AJ; Lin CH; Li M; Nishtala K; Alaei S; Rossello F; Sonntag C; Hersey L; Miles LB; Krisp C; Dudczig S; Fulcher AJ; Gibertini S; Conroy PJ; Siegel A; Mora M; Jusuf P; Packer NH; Currie PD
Nat Commun; 2021 May; 12(1):2951. PubMed ID: 34012031
[TBL] [Abstract][Full Text] [Related]
10. Biosynthetic Mechanisms and Biological Significance of Glycerol Phosphate-Containing Glycan in Mammals.
Imae R; Manya H; Endo T
Molecules; 2021 Nov; 26(21):. PubMed ID: 34771084
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a novel monoclonal antibody against truncated glycoforms of α-dystroglycan lacking matriglycans.
Yamasaki F; Umezawa F; Sensui T; Anzo M; Abo H; Kuo CW; Khoo KH; Kato K; Yagi H; Kawashima H
Biochem Biophys Res Commun; 2021 Nov; 579():8-14. PubMed ID: 34583196
[TBL] [Abstract][Full Text] [Related]
12. PCYT2 synthesizes CDP-glycerol in mammals and reduced PCYT2 enhances the expression of functionally glycosylated α-dystroglycan.
Imae R; Manya H; Tsumoto H; Miura Y; Endo T
J Biochem; 2021 Oct; 170(2):183-194. PubMed ID: 34255834
[TBL] [Abstract][Full Text] [Related]
13. Human embryoid bodies as a 3D tissue model of the extracellular matrix and α-dystroglycanopathies.
Nickolls AR; Lee MM; Zukosky K; Mallon BS; Bönnemann CG
Dis Model Mech; 2020 Jun; 13(6):. PubMed ID: 32423971
[TBL] [Abstract][Full Text] [Related]
14. Chemical and Chemo-Enzymatic Syntheses of Glycans Containing Ribitol Phosphate Scaffolding of Matriglycan.
Tamura JI; Tamura T; Hoshino S; Imae R; Kato R; Yokono M; Nagase M; Ohno S; Manabe N; Yamaguchi Y; Manya H; Endo T
ACS Chem Biol; 2022 Jun; 17(6):1513-1523. PubMed ID: 35670527
[TBL] [Abstract][Full Text] [Related]
15. Matriglycan maintains t-tubule structural integrity in cardiac muscle.
Hord JM; Anderson ME; Prouty SJ; Melton S; Gastel Z; Zimmerman K; Weiss RM; Campbell KP
Proc Natl Acad Sci U S A; 2024 May; 121(22):e2402890121. PubMed ID: 38771868
[TBL] [Abstract][Full Text] [Related]
16. Contrasting the conformational effects of α-O-GalNAc and α-O-Man glycan protein modifications and their impact on the mucin-like region of alpha-dystroglycan.
Borgert A; Foley BL; Live D
Glycobiology; 2021 Jun; 31(5):649-661. PubMed ID: 33295623
[TBL] [Abstract][Full Text] [Related]
17. Exploring the In situ pairing of human galectins toward synthetic O-mannosylated core M1 glycopeptides of α-dystroglycan.
Villones LL; Ludwig AK; Kumeta H; Kikuchi S; Ochi R; Aizawa T; Nishimura SI; Gabius HJ; Hinou H
Sci Rep; 2022 Oct; 12(1):17800. PubMed ID: 36274065
[TBL] [Abstract][Full Text] [Related]
18. Cancer Malignancy Is Correlated with Upregulation of PCYT2-Mediated Glycerol Phosphate Modification of α-Dystroglycan.
Umezawa F; Natsume M; Fukusada S; Nakajima K; Yamasaki F; Kawashima H; Kuo CW; Khoo KH; Shimura T; Yagi H; Kato K
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743105
[TBL] [Abstract][Full Text] [Related]
19. Identification of a short, single site matriglycan that maintains neuromuscular function in the mouse.
Yang T; Chandel I; Gonzales M; Okuma H; Prouty SJ; Zarei S; Joseph S; Garringer KW; Landa SO; Yonekawa T; Walimbe AS; Venzke DP; Anderson ME; Hord JM; Campbell KP
bioRxiv; 2023 Dec; ():. PubMed ID: 38187633
[TBL] [Abstract][Full Text] [Related]
20. Endogenous reductase activities for the generation of ribitol-phosphate, a CDP-ribitol precursor, in mammals.
Hoshino S; Manya H; Imae R; Kobayashi K; Kanagawa M; Endo T
J Biochem; 2024 Mar; 175(4):418-425. PubMed ID: 38140954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
